M
Mariam Jafri
Publications - 3
Citations - 231
Mariam Jafri is an academic researcher. The author has contributed to research in topics: Trastuzumab & Taxane. The author has an hindex of 2, co-authored 3 publications receiving 154 citations.
Papers
More filters
Journal ArticleDOI
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Helena M. Earl,Helena M. Earl,Helena M. Earl,Louise Hiller,Anne-Laure Vallier,Shrushma Loi,Karen McAdam,Karen McAdam,Luke Hughes-Davies,Adrian Harnett,Mei-Lin Ah-See,Richard Simcock,Daniel Rea,Sanjay Raj,Pamela Woodings,Mark Harries,Donna L. Howe,Kerry Raynes,Helen B Higgins,Maggie Wilcox,Chris Plummer,Chris Plummer,Janine Mansi,Ioannis Gounaris,Betania Mahler Araujo,Elena Provenzano,Elena Provenzano,Anita Chhabra,Jean Abraham,Jean Abraham,Jean Abraham,Carlos Caldas,Peter Hall,Christopher McCabe,Claire Hulme,Claire Hulme,David Miles,Andrew M Wardley,David Cameron,Janet A. Dunn,Roshan Agarwal,Hafiz Algurafi,Rozenn Allerton,Caroline Archer,Anne C Armstrong,Catherine Bale,Lisa H Barraclough,Urmila Barthakur,Carolyn Bedi,Kim Benstead,D. Bloomfield,Rebecca Bowen,Chris Bradley,Jane Brown,Mohammad Butt,Mark Churn,Susan Cleator,Joanne Cliff,Perric Crellin,Margaret Daly,Shiroma De Silva-Minor,A.S. Dhadda,O.S. Din,Sue Down,H. M. Earl,David J. Eaton,Andrew Eichholz,Daniel Epurescu,Chee Goh,Andrew D. Goodman,Robert Grieve,Maher Hadaki,Catherine Harper-Wynne,Larry Hayward,A. Humphreys,Helen Innes,Mariam Jafri,Apurna Jegannathen,Muireann Kelleher,Hartmut Kristeleit,Daniela Lee,Susan Lupton,Carol MacGregor,Zafar Malik,Jennifer Marshall,Trevor McGolick,Rakesh Mehra,Natasha Mithal,Charlotte Moss,Aian Moss,Mukesh Mukesh,Anthony Neal,Daniel Nelmes,Helen Neville-Webbe,Jacqueline Newby,S O'Reilly,Peter Ostler,Mojca Persic,Laura Pettit,Fharat A. Raja,Catherine Reed,Anne Rigg,Helen Roe,Nihal Shah,Peter Simmonds,Eliot Sims,Sarah Smith,Nicola Storey,Wendy Taylor,Narottam Thanvi,Karen Tipples,Jayant S. Vaidya,Mohini Varughese,Anup Vinayan,Nawaz Walji,Simon Waters,Kathryn Wright,Sundus Yahya +117 more
TL;DR: 6-month trastuzumab treatment is shown to be non-inferior to 12-month treatment in patients with HER2-positive early breast cancer, with less cardiotoxicity and fewer severe adverse events, which support consideration of reduced duration trastzumab for women at similar risk of recurrence as to those included in the trial.
Journal ArticleDOI
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Thomas Bachelot,Eva Ciruelos,Andreas Schneeweiss,Fabio Puglisi,T. Peretz-Yablonski,Igor Bondarenko,Shani Paluch-Shimon,Andrew M Wardley,J.-L. Merot,Y. du Toit,V. Easton,N. Lindegger,David Miles,K. Bouzid,Mario Campone,Bruno Coudert,Zbigniew Nowecki,Hassan Errihani,Florence Dalenc,Ana Ferreira,Max S. Mano,Francesco Ricci,Haralabos P. Kalofonos,Claudia Andreetta,Filippo Montemurro,Sophie Barrett,Qingyuan Zhang,Dimitris Mavroudis,Juan Matus,Carlos Beato,Xichun Hu,Rabab Gaafar,Hamdy Abdel Azeem,Christophe Perrin,Johannes Ettl,István Láng,Sunil Verma,Huiping Li,Etienne Brain,Oliver Hoffmann,Anna Cariello,Carlo Tondini,Taher Altwegeiri,Niklas Loman,Michael Lux,Antonio Frassoldati,Zeba Aziz,Fernando Salas,Joanna Streb,Andrzej Wronski,Salomón Menjón Beltrán,Irfan Cicin,Peter Schmid,Robert W. Laing,Zhongsheng Tong,Katalin Boér,Balazs Juhasz,Luca Gianni,Giuseppe Curigliano,Alejandro Juarez,Snezana Susnjar,Erika Matos,Ruchan Uslu,Hans Wildiers,Marcelo Rocha Cruz,Hugues Bourgeois,Raquel von Schumann,Salomon M. Stemmer,Flavia Morales Vásquez,Adriana Dominguez,Marek Z. Wojtukiewicz,Jasna Trifunovic,JJ Illarramendi,Laura Garcia,Yann Izarzugaza Peron,Maria Jose Echarri,Natliia Voitko,Duncan Wheatley,Simon Waters,Richard De Boer,Guy Jerusalem,Veronique Cocquyt,Carlos H. Barrios,Lawrence Panasci,Johanna Mattson,Minna Tanner,Michel Gozy,Georgios Vasilopoulos,János Révész,Luciano Latini,Cesare Gridelli,Jesus Lazaro,Antonio Gonzalez,Agusti Barnadas Molins,Eduardo Martinez,Jesús Alarcón,Ana Arance,Leif Klint,Oleksiy Kovalyov,Richard D. Baird,Belinda Yeo,Nicole McCarthy,Richard Greil,Shusen Wang,X. Artignan,Paule Augereau,Ingolf Juhasz-Boess,Roger K.C. Ngan,Hadassah Goldberg,Francesco Di Costanzo,Francesco Ferraù,Eduardas Aleknavicius,Kamran Rashid,Luís Costa,Jose Angel Garcia,Luis Ruiz de la Cruz,Rafael López,Olga Del Val,Ozgur Ozyilkan,Fathi Azribi,Mark Verrill,Nicholas C. Turner,Jane Beith,Andreas Petzer,Jurandyr Moreira de Andrade,Vanessa Bernstein,Daniel Rayson,Ibtessam Saad Eldin,Mihaëla Achille,Volkmar Mueller,Alessandra Gennari,Stefano Cascinu,Marwan Ghosn,Nagi S. El-Saghir,Joan Van den Bosch,Rianne Oosterkamp,Monika Kukulska,Ignacio Pelaez,Carolina Hernandez,Maria del Mar Gordon,Elsa Dalmau,Jose Luis Alonso,Sercan Aksoy,Hasan Şenol Coşkun,Yaroslav Shparyk,Mohini Varughese,Udaiveer Panwar,Lisa H Barraclough,Nicola Levitt,Jonathan Hicks,Anna Rigg,Mark Allen,Cecila Castillo,Luis Enrique Fein,Robin Stuart-Harris,Christian F. Singer,Herbert Stoeger,Sasha Smiljanic,Jifeng Feng,Miguel Cedeño,Jean-François Berdah,H. Orfeuvre,Anthony Goncalves,Eva-Maria Grischke,Eike Simon,Steffen Wagner,Anna Efremidou,Konstantinos Papazisis,Ella Evron,Moshe Inbar,Noa Ben Baruch,David B. Geffen,Natalya Karminsky,Enzo Maria Ruggeri,Cavanna Luigi,Donatella Grasso,Elona Juozaityte,Jeronimo Rafael Rodriguez Cid,Henk Roerdink,Neelum Siddiqi,José Luís Passos Coelho,Elisa Garcia Garre,Andres Garcia,Noelia Martinez Jañez,Maria Helena Lopez Ceballos,M Melé,Maria J. Garcia,Alberto Arcediano,Karen McAdam,Timothy J. Perren,Wendy Taylor,A. Humphreys,Raul Vera,Luis Alberto Kaen,Günther G. Steger,Johannes Andel,Jacques De Greve,Manon Huizing,Roberto Hegg,Anil A. Joy,Sandeep Sehdev,Riina Kütner,Johanna Ruohola,Nadine Dohollou,Jessica Grosjean,Philippe Laplaige,Rémy Largillier,Philippe Martin,Virginie Pottier,Jérôme Alexandre,Bernd Christensen,Dirk-Michael Zahm,Fariba Khandan,Hans-Joachim Lueck,Georgios Fountzilas,Georgeta Fried,Alice Giacobino,Andrea Bonetti,Yanin Chavarri Guerra,Laurens Van Warmerdam,Annette van der Velden,Suzan Vrijaldenhoven,Felix E de Jongh,Milagros Cavero,Raquel Andres Conejero,Adolfo Murias,Salvador Saura,Amparo Oltra,Andrés Redondo,Nuria Ribelles,Kilian Bachmeier,Johnathan Joffe,Prabir Chakraborti,Mark Beresford,Mohammad Butt,Christopher J. Poole,Gassan Yordi,Natasha Woodward,Gilberto Amorim,Nadia Califaretti,Susan Fox,Andre Robidoux,NanLi Li,Nenxiao Li,Jun Jiang,Tannia Soria,Peeter Padrik,Outi Saarni,Dominique Genet,Stéphanie Catala,Hugues Barletta,Luis Augusto Teixeira,Thomas Facchini,Tobias Hesse,Thorsten Kühn,Angelika Ober,Roland Repp,W. Schroeder,Dimitrios Pectasides,György Bodoky,Zsuzsanna Kahán,Irina Jiveliouk,Ora Rosengarten,Oscar Alabiso,Mario Perez,Yes Van de Wouw,Jolanta Smok-Kalwat,Margarida Damasceno,Gabriela Sousa,Omalkhair Abulkhair,A. Torres,Maria Purificación Martinez,Jesús Garcia Mata,Marta Santisteban Jesús Florián Jerico,Antonio Llombart,Rosa María Delgado Sánchez,Juan Carlos Torrego,Clara Olier Garate,César A. Rodríguez,Rosa Llorente,Diego Soto de Prado,Javier Cortes,Cristina Llorca,Antonio Galán,Gemma Viñas Villaro,Ulrik Narbe,Helena Granstam Bjömeklett,Sarah Westwell,Jackie Newby,Mariam Jafri,Robinson Rodriguez,Isabel Alonso +291 more
TL;DR: Paclitaxel appears to be a valid alternative taxane backbone to docetaxel, offering similar PFS and ORR with a predictable safety profile and preliminary findings from PERUSE suggest that the safety and efficacy of first-line pertuzumab, trastuzumAB and taxane for HER2-positive LR/MBC are consistent with results from CLEOPATRA.
Journal ArticleDOI
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
David Miles,Eva Ciruelos,Andreas Schneeweiss,Fabio Puglisi,T. Peretz-Yablonski,Mario Campone,Igor Bondarenko,Zbigniew Nowecki,Hassan Errihani,Shani Paluch-Shimon,A. Wardley,J.-L. Merot,Peter Trask,Y. du Toit,C. Pena-Murillo,V. Revelant,Dirk Klingbiel,Thomas Bachelot,K. Bouzid,I. Desmoulins,Bruno Coudert,I. Glogowska,E.M. Ciruelos Gil,Florence Dalenc,F. Ricci,V. Dieras,B. Kaufman,A. Ferreira,Max S. Mano,Haralabos P. Kalofonos,Claudia Andreetta,Filippo Montemurro,Sophie Barrett,Q. Zhang,Dimitris Mavroudis,J. Matus,C. Villarreal Garza,Carlos Beato,G. Ismael,X. Hu,H. Abdel Azeem,Rabab Gaafar,C. Perrin,P. Kerbrat,Johannes Ettl,S. Paepke,E. Hitre,István Láng,M. Trudeau,Sunil Verma,H. Li,O. Hoffmann,B. Aktas,A. Cariello,G. Cruciani,A. Tienghi,Carlo Tondini,T. Al-Twegieri,Niklas Loman,Robert W. Laing,Etienne Brain,P. Fasching,M. Lux,Antonio Frassoldati,Zeba Aziz,J. Salas,J. Streb,K. Krzemieniecki,A. Wronski,J.Á. García García,S. Menjon Beltran,Irfan Cicin,Peter Schmid,C. Gallagher,Nicholas C. Turner,Zhongsheng Tong,Katalin Boér,B. Juhász,Z. Horvath,G. Bianchini,Luca Gianni,Giuseppe Curigliano,A. Juarez Ramiro,S. Susnjar,E. Matos,E. Sevillano,L. Garcia Estevez,E. Gokmen,Ruchan Uslu,Hans Wildiers,F. Schutz,Marcelo Rocha Cruz,Hugues Bourgeois,R von Schumann,Salomon M. Stemmer,Adriana Dominguez,F. Morales-Vásques,Marek Z. Wojtukiewicz,J. Trifunovic,M.J. Echarri González,J.J. Illarramendi Mañas,E. Martinez de Dueñas,N. Voitko,J. Hicks,Simon Waters,P. Barrett-Lee,Duncan Wheatley,R. De Boer,Veronique Cocquyt,Guy Jerusalem,Carlos H. Barrios,Lawrence Panasci,J. Mattson,M. Tanner,M. Gozy,G. Vasilopoulos,C. Papandreou,János Révész,N. Battelli,G. Benedetti,L. Latini,Cesare Gridelli,J. Lazaro Leon,A.M. Arance Fernandez,A. Barnadas Molins,I. Calvo Plaza,R. Bratos,A. Gonzalez Martin,Y. Izarzugaza Peron,L. Klint,A. Kovalev,Nicole McCarthy,B. Yeo,D. Kee,J. Thomson,S. White,Richard Greil,Shusen Wang,X. Artignan,I. Juhasz-Böess,A. Rody,Roger K.C. Ngan,F. Dourleshter,H. Goldberg,L. Doni,F. Di Costanzo,F. Ferraù,M. Drobniene,E. Aleknavicius,Kamran Rashid,Luís Costa,L. de la Cruz Merino,J. A. Garcia Saenz,Rafael López,O. Del Val Munoz,Ozgur Ozyilkan,F. Azribi,H. Jaafar,R. Baird,Mark Verrill,Jane Beith,A. Petzer,J. Moreira de Andrade,V. Bernstein,N. Macpherson,D. Rayson,I. Saad Eldin,M. Achille,P. Augereau,V. Müller,A. Rasco,E. Evron,D. Katz,R. Berardi,Stefano Cascinu,A. De Censi,A. Gennari,Nagi S. El-Saghir,Marwan Ghosn,H.M. Oosterkamp,J. van den Bosch,M. Kukulska,E. Kalinka,J. Alonso,E. Dalmau Portulas,M. Del Mar Gordon Santiago,I. Pelaez Fernandez,Sercan Aksoy,K. Altundag,H. Senol Coskun,H. Bozcuk,Yaroslav Shparyk,Lisa H Barraclough,N. Levitt,Udaiveer Panwar,S. Kelly,A. Rigg,Mohini Varughese,C. Castillo,Luis Enrique Fein,L. Malik,R. Stuart-Harris,Christian F. Singer,H. Stoeger,H. Samonigg,Jifeng Feng,M. Cedeño,J. Ruohola,Jean-François Berdah,A. Goncalves,H. Orfeuvre,Eva-Maria Grischke,E. Simon,S. Wagner,G. Koumakis,Konstantinos Papazisis,N. Ben Baruch,G. Fried,David B. Geffen,N. Karminsky,T. Peretz,L. Cavanna,P. Pedrazzioli,Donatella Grasso,Enzo Maria Ruggeri,G. D’Auria,L. Moscetti,Elona Juozaityte,J. Rodriguez Cid,H. Roerdink,N. Siddiqi,J. Passos Coelho,A. Arcediano Del Amo,E. Garcia Garre,M. García Gonzalez,A. Garcia-Palomo Perez,C. Herenandez Perez,P. López Álvarez,M.H. Lopez De Ceballos,N. Martínez Jañez,M. Mele Olive,Karen McAdam,Timothy J. Perren,G. Dunn,A. Humphreys,Wendy Taylor,R. Vera,L. Kaen,Johannes Andel,Günther G. Steger,J. De Greve,M. Huizing,Roberto Hegg,Anil A. Joy,P. Kuruvilla,Sandeep Sehdev,S. Smiljanic,R. Kütner,Jérôme Alexandre,J. Grosjean,P. Laplaige,Rémy Largillier,P. Maes,Philippe Martin,V. Pottier,Bernd Christensen,F. Khandan,H.-J. Lück,D.-M. Zahm,Georgios Fountzilas,V. Karavasilis,T. Safra,M. Inbar,L. Ryvo,Andrea Bonetti,E. Seles,A. Giacobino,Y. Chavarri Guerra,F. de Jongh,A.M.T. van der Velden,L. J. C. van Warmerdam,S. Vrijaldenhoven,C.H. Smorenburg,M. Cavero,R. Andres Conejero,A. Oltra Ferrando,A. Redondo Sanchez,N. Ribelles Entrena,S. Saura Grau,G. Viñas Vilaro,K. Bachmeier,M. Beresford,Mohammad Butt,Johnathan Joffe,Christopher J. Poole,P. Woodings,Prabir Chakraborti,G. Yordi,Natasha Woodward,A. Nobre,G. Luiz Amorim,Nadia Califaretti,S. Fox,A. Robidoux,E. Li,N. Li,J. Jiang,T. Soria,Peeter Padrik,O. Lahdenpera,Hugues Barletta,Nadine Dohollou,D. Genet,K. Prulhiere,D. Coeffic,T. Facchini,S. Vieillot,S. Catala,Luis Augusto Teixeira,Tobias Hesse,T. Kühn,A. Ober,Roland Repp,W. Schröder,Dimitrios Pectasides,György Bodoky,Zsuzsanna Kahán,I. Jiveliouk,O. Rosengarten,V. Rossi,Oscar Alabiso,M. Pérez Martínez,A.J. van de Wouw,J. Smok-Kalwat,M. Damasecno,I. Augusto,G. Sousa,A. Saadein,N. Abdelhafiez,Omalkhair Abulkhair,A. Anton Torres,M. Corbellas Aparicio,R. Llorente Domenech,J. Florián Jerico,J. Garcia Mata,M. Gil Raga,A. Galan Brotons,A. Llombart Cussac,C. Llorca Ferrandiz,P. Martinez Del Prado,C. Olier Gárate,C.A. Rodríguez Sánchez,R. Sanchez Gomez,M. Santisteban Eslava,J. Soberino,M. Vidal Losada Garcia,D. Soto de Prado,J. Torrego Garcia,E. Vicente Rubio,Maria J. Garcia,A. Murias Rosales,H. Granstam Björneklett,U. Narbe,Mariam Jafri,D. Rea,J. Newby,A. Jones,S. Westwell,A. Ring,Isabel Alonso,Robinson Rodriguez +370 more
TL;DR: The phase III CLinical Evaluation Of Pertuzumab And TRAstuzumabs (CLEOPATRA) trial established the combination of pertuzumaab, trastuzumaba and docetaxel as standard first-line therapy for locally recurrent/metastatic breast cancer (LR/mBC).